Journal article · 2026 · Open access

Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes

Jeremy Mytskevych

Orbis Journal of Medical and Health Sciences, 1(1) · Published 28 June 2026 · DOI 10.68314/bw3krc30

Open full textCite this paper

In brief

“Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes” is a 2026 journal article by Jeremy Mytskevych, published in Orbis Journal of Medical and Health Sciences. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Orbis Journal of Medical and Health Sciences.

Citations
0
Authors
1

Abstract

Pharmacogenomics — the study of genetic variation and its influence on drug response — has ushered in a paradigm shift in clinical pharmacology with the potential to provide therapeutic treatment personalized to a patient's genetic architecture. Although sequencing technologies and pharmacogenomic databases have advanced substantially, the conversion of genotype to clinical relevance remains non-homogeneous across healthcare systems worldwide. A systematic literature search was conducted in PubMed/MEDLINE, Scopus, and CINAHL databases for publications from January 2020 to April 2025, screened according to PRISMA guidelines and relevant to pharmacogenomic biomarkers, gene-drug interactions, clinical implementation, and patient outcomes. Abundant evidence supports the clinical value of pharmacogenomic-guided therapy in oncology, psychiatry, cardiology, and infectious disease. Validated variants including CYP2C19, CYP2D6, TPMT, DPYD, HLA-B*57:01, SLCO1B1, and VKORC1 enable actionable clinical decision-making. Preemptive pharmacogenomic testing integrated with electronic health record clinical decision support reduces adverse drug reaction incidence, improves prescribing guideline concordance, and generates measurable cost savings. Systematic pharmacogenomics integration into clinical workflows through comprehensive clinical decision support systems and structured educational programs represents the most scalable strategy to realize precision medicine at the bedside.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mytskevych, J. (2026). Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes. Orbis Journal of Medical and Health Sciences, 1(1). https://doi.org/10.68314/bw3krc30

MLA 9

Mytskevych, Jeremy. “Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes.” Orbis Journal of Medical and Health Sciences, vol. 1, no. 1, 2026. https://doi.org/10.68314/bw3krc30.

Chicago

Mytskevych, Jeremy. 2026. “Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes.” Orbis Journal of Medical and Health Sciences 1 (1). https://doi.org/10.68314/bw3krc30.

Harvard

Mytskevych, J. (2026) ‘Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes’, Orbis Journal of Medical and Health Sciences, 1(1). doi:10.68314/bw3krc30.

IEEE

J. Mytskevych, “Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes,” Orbis Journal of Medical and Health Sciences, vol. 1, no. 1, 2026, doi: 10.68314/bw3krc30.

BibTeX

@article{mytskevych2026pharmacogenomics,
  title     = {{Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes}},
  author    = {Mytskevych, Jeremy},
  journal   = {Orbis Journal of Medical and Health Sciences},
  year      = {2026},
  volume    = {1},
  number    = {1},
  doi       = {10.68314/bw3krc30},
  url       = {https://doi.org/10.68314/bw3krc30}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • personalized medicine
  • drug-gene interactions
  • pharmacogenomic biomarkers
  • clinical decision support
  • electronic health records
  • adverse drug reactions
  • CYP2C19

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Mytskevych, J. (2026). Pharmacogenomics in Personalized Medicine: A Systematic Review of Gene-Drug Interactions and Clinical Outcomes. Orbis Journal of Medical and Health Sciences, 1(1). https://doi.org/10.68314/bw3krc30

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Orbis Journal of Medical and Health Sciences: sign in and open the full text from this page.

Who wrote this paper?

Jeremy Mytskevych.

What is the DOI of this paper?

10.68314/bw3krc30, permanently at https://doi.org/10.68314/bw3krc30. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.